https://www.selleckchem.com/pr....oducts/azeliragon.ht
30 ± 39.56 μg/g in the placebo group (difference estimate 16.90; 95% confidence interval -14.00, 47.77; P= .276). There were no significant differences between the treatment groups in changes of faecal or blood haemoglobin. Faecal B. lactis DNA was much more abundant in the B420 group compared to the placebo group (ANOVA estimate for treatment difference 0.85 × 10 /g faeces; 95% confidence interval 0.50 × 10 , 1.21 × 10 ; P .0001). Short-term administration of the probiotic B420 did not protect the healthy adult study participant
Like
Comment
Share
